Metabolic Karma-The Atherogenic Legacy of Diabetes: The 2017 Edwin Bierman Award Lecture
Mark Emmanuel Cooper, Assam El-Osta, Terri Jean Allen, Anna Margareta Dorothea Watson, Merlin Christopher Thomas, Karin Agnes Maria Jandeleit-Dahm
Diabetes | AMER DIABETES ASSOC | Published : 2018
M.E.C. has received grants and honoraria from companies making drugs currently used for management of diabetes and its complications, including Boehringer Ingelheim, Lilly, Novo Nordisk, AstraZeneca, and Bayer. M.C.T. has received honoraria for educational symposia conducted on behalf of pharmaceutical companies involved in the management of diabetes and its complications, including Boehringer Ingelheim, Lilly, AstraZeneca, Novartis, Merck Sharp & Dohme, Sanofi, Servier, and Mylan. No other potential conflicts of interest relevant to this article were reported.